How Medication-Assisted Treatment (MAT) Fits Into Outpatient Care in Troy, NY
August 11, 2026
.png)
Medication-assisted treatment is one of the most misunderstood tools in addiction care. For a lot of people, the phrase raises questions before it answers any. What medications? Combined with what? Is this just replacing one substance with another?
At our Troy outpatient clinic, MAT is one component within a broader clinical structure that includes counseling, group therapy, and in many cases, care for co-occurring mental health conditions. As a professional outpatient rehab center, we make sure it does not stand alone, and it is not a shortcut.
What MAT Actually Is
Medication-assisted treatment means using FDA-approved medications, alongside counseling and behavioral therapy, to treat substance use disorders. The medications are a clinical tool. They are not the whole treatment.
Medications by condition:
- Opioid use disorder: buprenorphine, methadone, or naltrexone
- Alcohol use disorder: naltrexone, acamprosate, and disulfiram
The most persistent misconception is that MAT simply trades one dependency for another. That misrepresents how these medications work neurologically. These are clinical mechanisms, not substitutions:
- Buprenorphine and methadone stabilize brain chemistry, reduce cravings, and ease withdrawal symptoms at a consistent therapeutic dose. They allow a person to function, engage meaningfully with therapy, maintain work and family obligations, and stay in treatment long enough for the counseling work to matter.
- Naltrexone operates differently, blocking opioid receptors rather than stimulating them, which reduces the reward a person gets from using.
The Medications We Use at Our Troy Clinic
Methadone is a long-acting opioid agonist used for opioid dependence, administered daily at the clinic under clinical supervision. For people with severe opioid use disorder, particularly those with a longer history of use, methadone maintenance has a strong evidence base for:
- Reducing illicit opioid use
- Supporting sustained recovery
- Providing consistent clinical contact, which has its own stabilizing value during early treatment
Buprenorphine, available as Suboxone and Subutex, works similarly but can be prescribed for take-home use once a patient is stable. Our intensive outpatient program includes:
- Buprenorphine induction and maintenance
- Same-day induction for qualifying cases, particularly when a person is in active withdrawal and ready to start
Naltrexone, including the extended-release injectable form known as Vivitrol, is appropriate for people who have completed detox and want a medication that blocks the rewarding effects of opioids or alcohol going forward. It is best suited for individuals who are:
- Fully detoxed and opioid-free
- Motivated to prevent relapse to opioids or alcohol
- Seeking a non-opioid, non-habit-forming treatment option
For alcohol use disorder specifically, Acamprosate and Disulfiram are also part of the formulary at our Troy clinic.
.jpg)
How MAT Works Alongside Counseling
MAT is not managed in isolation at our clinic. For every patient on medication, there are group sessions, individual counseling appointments, and regular clinical check-ins built into the treatment schedule. The medication side and the behavioral health side are designed to inform each other. Not run in parallel like two separate programs that never talk.
This matters because medication handles the physiological part of addiction, and counseling handles everything else. The behavioral patterns, the psychological weight, the situational stuff that keeps pulling people back. A person stable on buprenorphine but still surrounded by the same circumstances that drove their use, you know, that is a person who is still at risk.
That is exactly where a structured relapse prevention plan comes in. The counseling and group work are where those patterns get examined and, bit by bit, changed. Medication creates the conditions for that work to actually happen. At our Troy clinic, both pieces are built into the same coordinated plan from the start.
Who MAT Is Clinically Appropriate For
MAT is most clearly supported for opioid use disorder and alcohol use disorder. Whether MAT is the right fit for a specific person is always determined through the initial assessment, not assumed in advance.
Opioid Use Disorder
For opioid dependence, medication is often the clinical recommendation that produces the most durable results, particularly when a person has:
- A history of multiple relapses
- A strong physiological component to their dependence
- Previous outpatient attempts without MAT that did not hold
Alcohol Use Disorder
For alcohol use disorder, the case for medication is less universally understood but equally well-supported in clinical literature. Key medications include:
- Naltrexone significantly reduces craving and the rewarding effects of alcohol.
- Acamprosate supports abstinence in people who have already stopped drinking.
These are not last-resort options. They are first-line treatments with meaningful clinical backing.
The First Steps for Starting MAT in Troy
Every MAT prescription at our clinic follows a clinical assessment. There is no medication before evaluation. The assessment covers substance use history, physical health, current medications, and any mental health conditions that factor into the medication plan. That full picture shapes what medications are recommended and at what doses.
The process moves quickly from there. Same-day MAT is available in qualifying cases, particularly for buprenorphine induction when a patient is in active withdrawal and ready to begin. Walk-ins are welcome at our Troy location during clinic hours, and assessments are typically scheduled within 24 hours of first contact.
If you have questions about whether MAT is covered by your insurance, our admissions team can verify your benefits before your first appointment so there are no unexpected costs when you arrive.
MAT and Co-Occurring Mental Health Conditions
For people managing both a substance use disorder and a mental health condition, MAT can be integrated alongside psychiatric medication management and the dual-focused group work that is part of our co-occurring disorder program in Troy. These are not treated as separate concerns handled by separate providers. One clinical team, one coordinated care plan, addressing the full picture.
Mental health conditions affect how a person moves through early recovery in specific ways. Anxiety and depression can intensify during the early weeks off substances, and PTSD symptoms can surface when the numbing effect of substance use is removed. Our clinical team accounts for these dynamics from the start of treatment, not as complications to be addressed after the addiction piece is stable.
Related Topics:
.jpg)
.png)
.png)
